Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-05 Purchase | 2019-09-09 5:09 pm | NEKTAR THERAPEUTICS | NKTR | Doberstein Stephen K SVP & Chief Scientific Officer | 15,000 | $17.28 | $259,200 | 107,668 (Direct) | View |
| 2019-08-16 Sale | 2019-08-19 7:06 pm | NEKTAR THERAPEUTICS | NKTR | Doberstein Stephen K SVP & Chief Scientific Officer | 3,245 | $18.15 | $58,897 | 92,668 (Direct) | View |
| 2019-05-16 Sale | 2019-05-17 8:18 pm | NEKTAR THERAPEUTICS | NKTR | Doberstein Stephen K SVP & Chief Scientific Officer | 3,461 | $31.37 | $108,572 | 95,913 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-19 Option Award | 2023-09-20 5:48 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 5:08 pm | N/A 2032-06-01 | Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 5:11 pm | N/A 2032-05-12 | Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-12-28 Disposition | 2021-12-29 4:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director | 58,333 | $0 | 0 (Direct) | View |
| 2021-12-28 Equity Swap | 2021-12-29 4:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director | 3,333 | $38.25 | 0 (Direct) | View |
| 2021-06-03 Exercise | 2021-06-07 9:32 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director | 3,333 | $0 | 21,666 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 9:32 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director | 18,333 | $0 | 21,666 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-16 8:02 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director | 18,333 | $0 | 18,333 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 8:31 pm | N/A 2030-03-11 | Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director | 25,000 | $0 | 25,000 (Direct) | View |